Literature DB >> 8393247

Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication.

M S Freistadt1, H B Fleit, E Wimmer.   

Abstract

In order to determine whether any primary human blood cells have the ability to replicate poliovirus (PV), peripheral blood cell components were isolated and analyzed for their cell surface expression of the poliovirus receptor (PVR). Following two-color immunfluoresence staining with lineage-specific markers, the cells were analyzed by flow-cytometric methods. PVR cell surface expression was detected on most mononuclear cells expressing CD14, a marker for mononuclear phagocytes. There was no PVR cell surface expression on platelets and extremely low levels on polymorphonuclear leukocytes. Mononuclear leukocytes from Ficoll density centrifugation were found to support PV replication. The finding of PVR on mononuclear phagocytes and the ability of primary human blood cells to support PV replication in the absence of cultivation has implications for both the normal and pathogenic role of PVR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393247     DOI: 10.1006/viro.1993.1433

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  Dendritic cells and macrophages are productively infected by poliovirus.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.

Authors:  Noa Stanietsky; Hrvoje Simic; Jurica Arapovic; Amir Toporik; Ofer Levy; Amit Novik; Zurit Levine; Meirav Beiman; Liat Dassa; Hagit Achdout; Noam Stern-Ginossar; Pinhas Tsukerman; Stipan Jonjic; Ofer Mandelboim
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

Review 3.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

4.  Polio, still lurking in the shadows.

Authors:  Anthony N van den Pol
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

5.  Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.

Authors:  Vidyalakshmi Chandramohan; Jeffrey D Bryant; Hailan Piao; Stephen T Keir; Eric S Lipp; Michaela Lefaivre; Kathryn Perkinson; Darell D Bigner; Matthias Gromeier; Roger E McLendon
Journal:  Arch Pathol Lab Med       Date:  2017-08-22       Impact factor: 5.534

6.  The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation.

Authors:  P A Benton; D J Barrett; R L Matts; R E Lloyd
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.

Authors:  Shaukat Khan; Hidemi Toyoda; Melissa Linehan; Akiko Iwasaki; Akio Nomoto; Günter Bernhardt; Jeronimo Cello; Eckard Wimmer
Journal:  J Gen Virol       Date:  2014-04-30       Impact factor: 3.891

8.  TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.

Authors:  Joe-Marc Chauvin; Ornella Pagliano; Julien Fourcade; Zhaojun Sun; Hong Wang; Cindy Sander; John M Kirkwood; Tseng-hui Timothy Chen; Mark Maurer; Alan J Korman; Hassane M Zarour
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

Review 9.  Oncolytic polio virotherapy of cancer.

Authors:  Michael C Brown; Elena Y Dobrikova; Mikhail I Dobrikov; Ross W Walton; Sarah L Gemberling; Smita K Nair; Annick Desjardins; John H Sampson; Henry S Friedman; Allan H Friedman; Douglas S Tyler; Darell D Bigner; Matthias Gromeier
Journal:  Cancer       Date:  2014-06-17       Impact factor: 6.860

10.  Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.

Authors:  Alain Haddad; M Reza Nokhbeh; David A Alexander; Sandra J Dawe; Christine Grisé; Naveed Gulzar; Kenneth Dimock
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.